Press Releases

Cardinal Health's Outcomes™ business will combine with Transaction Data Systems to offer improved patient engagement and clinical pharmacy solutions, expanding connections between payers and...

Cardinal Health (NYSE: CAH) today launched modern payment solutions, powered by Square, to help independent pharmacies increase operational efficiency, stay current with customer payment...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to the Company's quarterly dividend, to $0.5006 per share, out of the Company's capital surplus. The...

Revenue increased 13% to $50.5 billion GAAP1 operating earnings were $572 million; GAAP diluted EPS was $1.34 Non-GAAP operating earnings increased 11% to $606 million; non-GAAP diluted EPS...

Cardinal Health (NYSE: CAH) announced today the launch of the first-of-its-kind Stray Away™ hair management drape for more efficient surgical procedure preparation. The Stray Away™ drape is...

The new facilities represent Cardinal Health's ongoing commitment to servicing customers, warehousing modernization and growing the local economy DUBLIN, Ohio, April 17, 2023 /PRNewswire/ --...

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2023 on May 4, prior to the opening of trading on the New York Stock Exchange. The company will...

Cardinal Health (NYSE:CAH) today announced its collaboration with Signify Health (NYSE:SGFY) to offer in-home clinical and medication management services through its Outcomes™ business. This...

Study reveals provider perceptions of commercially available biosimilars and anticipated launches, which have the potential to increase equitable access to critical treatments DUBLIN, Ohio, Feb....

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4957 per share out of the Company's capital surplus. The dividend will be payable on...

Revenue increased 13% to $51.5 billion GAAP1 operating loss was $119 million due to a non-cash, pre-tax goodwill impairment of $709 million related to the Medical segment; GAAP diluted loss per...

The platform will combine and analyze datasets for live purchasing decision support of pharmaceuticals DUBLIN, Ohio and DENVER, Jan. 26, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced...

Committed to becoming a more sustainable healthcare partner, the company makes meaningful progress in key ESG areas DUBLIN, Ohio, Jan. 25, 2023 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH)...

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2023 on February 2, prior to the opening of trading on the New York Stock Exchange. The company...

Cardinal Health (NYSE: CAH) and its board of directors announced today that Aaron Alt will become the company's new chief financial officer (CFO). Alt will succeed interim CFO, Trish English and...

Cardinal Health (NYSE: CAH) released today its latest edition of Oncology Insights, a biannual, research-based report from Cardinal Health. Featuring perspectives from nearly 200 oncologists...

Launching as a pilot with Medically Home, new technology offering will reach patients in one to two hours DUBLIN, Ohio, Nov. 15, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4957 per share out of the Company's capital surplus. The dividend will be payable on...

Revenue increased 13% to $49.6 billion GAAP1 operating earnings were $137 million, GAAP diluted EPS were $0.40 Non-GAAP operating earnings decreased 20% to $423 million due to a decline in Medical...

Today, Cardinal Health (NYSE: CAH) released its third edition of Rheumatology Insights, a research report based on surveys with more than 100 rheumatologists nationwide that focuses on key trends...

Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2023 on November 4, prior to the opening of trading on the New York Stock Exchange. The company...

--Victor Crawford will step down as CEO of Pharmaceutical Segment-- --Debbie Weitzman, President of Pharmaceutical Distribution, named CEO of Pharmaceutical Segment-- DUBLIN, Ohio, Sept. 8, 2022...

Adds Four New Independent Directors to the Board Forms New Business Review Committee to Evaluate Portfolio and Operations DUBLIN, Ohio, Sept. 6, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH)...

Revenue increased 11% to $47.1 billion in the fourth quarter GAAP1 operating earnings were $36 million in the fourth quarter; GAAP diluted EPS were $0.50 in the fourth quarter Non-GAAP operating...